CANCER PATHOLOGY CLAIMS
pathology, medical malpractice, claimed, missed pathology, claim against pathologist, negligence, medical malpractice.
The pathology is a potential defendant and the attached article discusses
claims.
Troxel, Medicolegal aspects of error in pathology, Arch Pathol Lab Med. 2006
May;130(5):617-9.
School of Public Health, University of California, Berkeley, California, USA.
dtroxel@thedoctors.com
OBJECTIVE: To discuss the various ways error is defined in surgical pathology.
To identify errors in pathology practice identified by an analysis of pathology
malpractice claims. DESIGN: Three hundred seventy-eight pathology malpractice
claims were reviewed. Nuisance claims and autopsy claims were excluded; 335
pathology claims remained and were analyzed to identify repetitive patterns of
specimen type and diagnostic category. SETTING: All pathology malpractice claims
reported to The Doctors Company of Napa, Calif, between 1998 and 2003. RESULTS:
Fifty-seven percent of malpractice claims involved just 5 categories of specimen
type and/or diagnostic error, namely, breast specimens, melanoma, cervical
Papanicolaou tests, gynecologic specimens, and system (operational) errors.
Sixty-three percent of claims involved failure to diagnose cancer, resulting in
delay in diagnosis or inappropriate treatment. CONCLUSION: A false-negative
diagnosis of melanoma was the single most common reason for filing a malpractice
claim against a pathologist. Nearly one third involved melanoma misdiagnosed as
Spitz nevus, "dysplastic" nevus, spindle cell squamous carcinoma, atypical
fibroxanthoma, and dermatofibroma. While breast biopsy claims were a close
second to melanoma, when combined with breast fine-needle aspiration and breast
frozen section claims, breast specimens were the most common cause of pathology
malpractice claims. Cervical Papanicolaou test claims were third in frequency
behind melanoma and breast; 98% involved false-negative Papanicolaou tests.
Forty-two percent of gynecologic surgical pathology claims involved misdiagnosed
ovarian tumors, and 85% of these were false-negative diagnoses of malignancy.
The most common cause of system errors was specimen "mix-ups" involving breast
or prostate needle biopsies.
MEDICAL MALPRACTICE
LINKS
Failure to diagnose cancer, doctor's defenses
Malpractice and standard of care
Failure to Detect Lung
Cancer claims
What is cancer (chapter one from our upcoming book, A Complete Guide to Lung Cancer)
medical malpractice and standard of
care
(a journal discussing medical malpractice standards of care
including failure to diagnose cancer)
New York medical malpractice
claims
medical
malpractice lung cancer claims
cancer malpractice statute of limitations
New York Cancer Malpractice claims medical
malpractice and clinical practice guidelines
New Jersey cancer malpractice claims
medical malpractice liability
Medical malpractice jury instruction
New
York Medical malpractice law
medical malpractice pre-existing cause
workers' compensation doctor liability for malpractice
cancer, malpractice and informed consent
lung cancer
malpractice claim elements
Delayed
diagnosis of cancer Kern article
Cancer pathology claims
Delayed diagnosis of cancer Sign
article
How to contact us:
Law Offices of Howard A. Gutman,
230 Route 206, Mount Olive, New Jersey 07836
(973) 598-1980, E-mail Howian@aol.com
New York Office
305 Madison Avenue, Suite 449
New York, New York 10165 (212) 886-4838
FREE INITIAL CONSULTATION
We offer a free telephone consultation to discuss your case. Please feel free to call or e-mail our office.
keywords: medical malpractice, claim,
attorney, failure to diagnose cancer, negligence,
malpractice, delayed diagnosis, standard of care,
missed diagnosis, New Jersey medical malpractice lawyer, New York medical
malpractice lawyer.
About Us
Mr. Gutman is the author of lung cancer and
mesothelioma, 480 page book which reviews
chemotherapy, gene therapy, radiation, treatment for lung cancer, and medical
malpractice questions. He served as a caregiver for a family member
with lung cancer, was a member of the board of directors of a leading cancer
support group, and is an attorney specializing in lung cancer legal issues. He
combines the intellectual knowledge of someone who handles issues of lung cancer
with the personal approach of someone who has dealt with cancer and confronted
many of the difficult questions patients and family members confront.